Opioid Prescribing for Kidney Stone Formers Undergoing Stone Removal

Nikhi P. Singh, Joseph J. Crivelli, William Poore, Zachary R. Burns, Robert A. Oster, Dean G. Assimos, Kyle D. Wood

Abstract


Background: Kidney stone formers may have episodes of severe pain and be at increased risk of narcotic use. Alabama has a high rate of opioid use. Within, we examine differences in opioid prescribing for kidney stone formers requiring stone removal procedures.

Methods: A retrospective review was conducted from June 2013 to July 2019. Twenty-five patients with recurrent cystine stones were randomly matched by age, gender, and procedure to 25 recurrent non-cystine and 25 first-time non-cystine stone formers. Patients underwent ureteroscopic stone removal and percutaneous nephrolithotomy. Opioids prescribed were identified through medical record review and the prescription drug monitoring program (PDMP) database. Morphine milligram equivalents (MMEs) standardized opioid utilization.

Results: Opioids prescribed at discharge significantly decreased (mean MME ± SD), 216.8 ± 125.9 for 2013 - 2016 and 124.2 ± 106.1 for 2017 - 2019 (P < 0.001) corresponding to implementation of an institutional opioid stewardship program. Opioids prescribed within 180 days of stone removal were similar amongst all three cohorts, mean 3,377.6 MME/patient. Over this 6-year time period, there was no difference in total amount of opioids prescribed for each cohort, mean 27,987.8 MME. The majority of prescriptions (56.4%) and MME prescribed (91.9 %) were from pain management and primary care providers.

Conclusions: MME prescribed for stone removal in an environment of high utilization has not declined and is not influenced by stone disease complexity. An opioid stewardship program was associated with decreased opioids prescribed by the surgeons conducting stone removal but had a negligible overall influence. The latter is driven by other care providers.




World J Nephrol Urol. 2022;11(1):10-17
doi: https://doi.org/10.14740/wjnu428

Keywords


Opioids; Opioid epidemic; Kidney stone disease; Ureteroscopy; Percutaneous nephrolithotomy

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

World Journal of Nephrology and Urology, quarterly, ISSN 1927-1239 (print), 1927-1247 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.wjnu.org   editorial contact: editor@wjnu.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
© Elmer Press Inc. All Rights Reserved.